A citation-based method for searching scientific literature

Julian P T Higgins, Simon G Thompson. Stat Med 2002
Times Cited: 18747







List of co-cited articles
67 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Bias in meta-analysis detected by a simple, graphical test.
M Egger, G Davey Smith, M Schneider, C Minder. BMJ 1997
32

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. PLoS Med 2009
16

Meta-analysis in clinical trials.
R DerSimonian, N Laird. Control Clin Trials 1986
14

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.
David Moher, Larissa Shamseer, Mike Clarke, Davina Ghersi, Alessandro Liberati, Mark Petticrew, Paul Shekelle, Lesley A Stewart. Syst Rev 2015
13

Measuring inconsistency in meta-analyses.
Julian P T Higgins, Simon G Thompson, Jonathan J Deeks, Douglas G Altman. BMJ 2003
13

Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.
D F Stroup, J A Berlin, S C Morton, I Olkin, G D Williamson, D Rennie, D Moher, B J Becker, T A Sipe, S B Thacker. JAMA 2000
10

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. BMJ 2009
9

Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials.
Jonathan A C Sterne, Alex J Sutton, John P A Ioannidis, Norma Terrin, David R Jones, Joseph Lau, James Carpenter, Gerta Rücker, Roger M Harbord, Christopher H Schmid,[...]. BMJ 2011
9

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.
Matthew J Page, Joanne E McKenzie, Patrick M Bossuyt, Isabelle Boutron, Tammy C Hoffmann, Cynthia D Mulrow, Larissa Shamseer, Jennifer M Tetzlaff, Elie A Akl, Sue E Brennan,[...]. BMJ 2021
8


Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. J Clin Epidemiol 2009
6

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.
Julian P T Higgins, Douglas G Altman, Peter C Gøtzsche, Peter Jüni, David Moher, Andrew D Oxman, Jelena Savovic, Kenneth F Schulz, Laura Weeks, Jonathan A C Sterne. BMJ 2011
6


RoB 2: a revised tool for assessing risk of bias in randomised trials.
Jonathan A C Sterne, Jelena Savović, Matthew J Page, Roy G Elbers, Natalie S Blencowe, Isabelle Boutron, Christopher J Cates, Hung-Yuan Cheng, Mark S Corbett, Sandra M Eldridge,[...]. BMJ 2019
5

Estimating the mean and variance from the median, range, and the size of a sample.
Stela Pudar Hozo, Benjamin Djulbegovic, Iztok Hozo. BMC Med Res Methodol 2005
5

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher. PLoS Med 2009
5


Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.
Pouya Saeedi, Inga Petersohn, Paraskevi Salpea, Belma Malanda, Suvi Karuranga, Nigel Unwin, Stephen Colagiuri, Leonor Guariguata, Ayesha A Motala, Katherine Ogurtsova,[...]. Diabetes Res Clin Pract 2019
4


Interpretation of random effects meta-analyses.
Richard D Riley, Julian P T Higgins, Jonathan J Deeks. BMJ 2011
4

Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions.
Miranda Cumpston, Tianjing Li, Matthew J Page, Jacqueline Chandler, Vivian A Welch, Julian Pt Higgins, James Thomas. Cochrane Database Syst Rev 2019
4

A basic introduction to fixed-effect and random-effects models for meta-analysis.
Michael Borenstein, Larry V Hedges, Julian P T Higgins, Hannah R Rothstein. Res Synth Methods 2010
3

Meta-analysis in medical research.
A B Haidich. Hippokratia 2010
357
3

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.
Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher. BMJ 2009
3

Meta-analysis in clinical trials revisited.
Rebecca DerSimonian, Nan Laird. Contemp Clin Trials 2015
3

GRADE guidelines: 3. Rating the quality of evidence.
Howard Balshem, Mark Helfand, Holger J Schünemann, Andrew D Oxman, Regina Kunz, Jan Brozek, Gunn E Vist, Yngve Falck-Ytter, Joerg Meerpohl, Susan Norris,[...]. J Clin Epidemiol 2011
3

The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations.
Brian Hutton, Georgia Salanti, Deborah M Caldwell, Anna Chaimani, Christopher H Schmid, Chris Cameron, John P A Ioannidis, Sharon Straus, Kristian Thorlund, Jeroen P Jansen,[...]. Ann Intern Med 2015
3

AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both.
Beverley J Shea, Barnaby C Reeves, George Wells, Micere Thuku, Candyce Hamel, Julian Moran, David Moher, Peter Tugwell, Vivian Welch, Elizabeth Kristjansson,[...]. BMJ 2017
3

Uncertainty in heterogeneity estimates in meta-analyses.
John P A Ioannidis, Nikolaos A Patsopoulos, Evangelos Evangelou. BMJ 2007
741
3

How to perform a meta-analysis with R: a practical tutorial.
Sara Balduzzi, Gerta Rücker, Guido Schwarzer. Evid Based Ment Health 2019
729
3

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.
Jonathan Ac Sterne, Miguel A Hernán, Barnaby C Reeves, Jelena Savović, Nancy D Berkman, Meera Viswanathan, David Henry, Douglas G Altman, Mohammed T Ansari, Isabelle Boutron,[...]. BMJ 2016
3

Practical methods for incorporating summary time-to-event data into meta-analysis.
Jayne F Tierney, Lesley A Stewart, Davina Ghersi, Sarah Burdett, Matthew R Sydes. Trials 2007
3

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. Int J Surg 2010
3

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.
Gordon H Guyatt, Andrew D Oxman, Gunn E Vist, Regina Kunz, Yngve Falck-Ytter, Pablo Alonso-Coello, Holger J Schünemann. BMJ 2008
3

Assessing the quality of reports of randomized clinical trials: is blinding necessary?
A R Jadad, R A Moore, D Carroll, C Jenkinson, D J Reynolds, D J Gavaghan, H J McQuay. Control Clin Trials 1996
2

Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement.
Damian Hoy, Peter Brooks, Anthony Woolf, Fiona Blyth, Lyn March, Chris Bain, Peter Baker, Emma Smith, Rachelle Buchbinder. J Clin Epidemiol 2012
2

Metaprop: a Stata command to perform meta-analysis of binomial data.
Victoria N Nyaga, Marc Arbyn, Marc Aerts. Arch Public Health 2014
977
2

Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps.
Amedeo Lonardo, Fabio Nascimbeni, Stefano Ballestri, DeLisa Fairweather, Sanda Win, Tin A Than, Manal F Abdelmalek, Ayako Suzuki. Hepatology 2019
218
2

Controlling the risk of spurious findings from meta-regression.
Julian P T Higgins, Simon G Thompson. Stat Med 2004
757
2

Meta-analysis and subgroups.
Michael Borenstein, Julian P T Higgins. Prev Sci 2013
202
2

Conducting quantitative synthesis when comparing medical interventions: AHRQ and the Effective Health Care Program.
Rongwei Fu, Gerald Gartlehner, Mark Grant, Tatyana Shamliyan, Art Sedrakyan, Timothy J Wilt, Lauren Griffith, Mark Oremus, Parminder Raina, Afisi Ismaila,[...]. J Clin Epidemiol 2011
242
2


Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation.
Nikolaos A Patsopoulos, Evangelos Evangelou, John P A Ioannidis. Int J Epidemiol 2008
541
2

Reliability of the PEDro scale for rating quality of randomized controlled trials.
Christopher G Maher, Catherine Sherrington, Robert D Herbert, Anne M Moseley, Mark Elkins. Phys Ther 2003
2

Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data.
Zachary Munn, Sandeep Moola, Karolina Lisy, Dagmara Riitano, Catalin Tufanaru. Int J Evid Based Healthc 2015
606
2

Beneficial impact of sleep extension on fasting insulin sensitivity in adults with habitual sleep restriction.
Rachel Leproult, Gaétane Deliens, Médhi Gilson, Philippe Peigneux. Sleep 2015
97
2

Metabolic and hormonal effects of 'catch-up' sleep in men with chronic, repetitive, lifestyle-driven sleep restriction.
Roo Killick, Camilla M Hoyos, Kerri L Melehan, George C Dungan, Jonathon Poh, Peter Y Liu. Clin Endocrinol (Oxf) 2015
57
3

How should meta-regression analyses be undertaken and interpreted?
Simon G Thompson, Julian P T Higgins. Stat Med 2002
2

GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes.
Gordon Guyatt, Andrew D Oxman, Shahnaz Sultan, Jan Brozek, Paul Glasziou, Pablo Alonso-Coello, David Atkins, Regina Kunz, Victor Montori, Roman Jaeschke,[...]. J Clin Epidemiol 2013
381
2



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.